Superficial femoral artery (SFA)

Video

The NEW 2.00 Max Crown in Long SFA Lesion

04/06/2023

Ankur Lodha, MD

Cardiovascular Institute of the South, Lafayette, Louisiana

Ankur Lodha, MD Cardiovascular Insti...

Dr. Lodha, an interventional cardiologist, takes a radial approach and safely treats moderately calcified lesions in the SFA and popliteal arteries.

Dr. Lodha, an interventional...

04/06/2023

Vascular Disease Management

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Stefanos Giannopoulos, MD¹; Eric A. Secemsky, MD²; Peter A. Schneider, MD³; Ehrin J. Armstrong, MD¹

Stefanos Giannopoulos, MD1; Eric A. ...

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Calcium Corner

Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions

01/01/2020

An interview with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.

An interview with IMPERIAL trial co-p...

The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.

The Eluvia stent utilizes a...

01/01/2020

Cath Lab Digest

Case Report

Interventional Therapy of Complex Superficial Femoral Artery Disease Via Femoral-Femoral Crossover Graft

07/31/2019

Scott Baron¹, MD, FACC, FSCAI, Arvin Arthur, MD, FACC, FSCAI, Mohammed Nazir, RCIS, Mercy San Juan Medical Center, Carmichael, California

Scott Baron1, MD, FACC, FSCAI, Arvin ...

This case adds insight into the benefit of complementary endovascular technologies with difficult vascular surgery to improve outcomes in complex peripheral vascular disease.

This case adds insight into the...

07/31/2019

Cath Lab Digest

Case Report

Optimizing Success in Treating Occlusive Disease of the Superficial Femoral Artery

12/07/2015

Vinayak Subramaniana, BS, George L. Adamsb, MD, MHS, Orlando Marreroc, RCIS, MBA

Vinayak Subramaniana, BS, George L. A...

The superficial femoral artery (SFA) is unlike any other vessel in the body and presents unique challenges for endovascular intervention. Complete occlusions tend to predominate stenosis, and disease is often diffuse along the SFA.

The superficial femoral artery...

12/07/2015

Cath Lab Digest

Case Report

Revascularization of Superficial Femoral Artery Chronic Total Occlusion

03/30/2012

Emerging technologies constantly redefine the clinical landscape in the treatment of PAD We describe a case utilizing the adjunctive therapy of the Wildcat catheter with the motorized Juicebox console (Avinger, Inc.) in crossing a complex...

Emerging technologies constantly...

03/30/2012

Vascular Disease Management

Original Research

Initial Experience in the Treatment of Chronic Superficial Femoral Artery Occlusion with Fiberoptic Guidance Technology

09/05/2008

Romas Kirvaitis, MD; Richard Heuser, MD

Romas Kirvaitis, MD; Richard Heuser, ...

Percutaneous treatment of chronic total occlusions may result in dissection or perforation. A fiberoptic guidance system that visualizes lesion characteristics and incorporates a radiofrequency energy source to aid in crossing total...

Percutaneous treatment of...

09/05/2008

Vascular Disease Management